TINA NORDEEN: Open Payments
NPI 1932789674 · AIKEN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,913 in 226 payments from 30 companies in 2025. Trend: 2023 $4,351 · 2024 $4,409 · 2025 $4,913
Food & beverage: $4,913
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $728 |
| Teva Pharmaceuticals USA, Inc. | 56 | $521 |
| UCB, Inc. | 17 | $442 |
| ACADIA Pharmaceuticals Inc | 10 | $332 |
| Neurocrine BioSciences, Inc. | 9 | $289 |
| Lundbeck LLC | 11 | $257 |
| Novartis Pharmaceuticals Corporation | 10 | $234 |
| Otsuka America Pharmaceutical, Inc. | 6 | $225 |
| PFIZER INC. | 12 | $218 |
| Alexion Pharmaceuticals, Inc. | 4 | $194 |
Products named: QULIPTA, AUSTEDO XR, NUPLAZID, INGREZZA, Leqembi, VYEPTI, REXULTI, KESIMPTA.
Industry payments across SC — which companies pay providers there.
